SPARTANNASH ($SPTN) posted quarterly earnings results on Wednesday, February 12th. The company reported earnings of $0.42 per share, beating estimates of $0.32 by $0.10. The company also reported revenue of $2,261,620,000, missing estimates of $2,297,218,500 by $-35,598,500.
You can see Quiver Quantitative's $SPTN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SPARTANNASH Hedge Fund Activity
We have seen 96 institutional investors add shares of SPARTANNASH stock to their portfolio, and 124 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ELLSWORTH ADVISORS, LLC removed 223,742 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $4,098,953
- PHOCAS FINANCIAL CORP. removed 186,550 shares (-85.0%) from their portfolio in Q4 2024, for an estimated $3,417,596
- LSV ASSET MANAGEMENT added 142,879 shares (+17.6%) to their portfolio in Q3 2024, for an estimated $3,201,918
- CX INSTITUTIONAL removed 138,395 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $3,101,431
- AMERICAN CENTURY COMPANIES INC added 129,907 shares (+14.2%) to their portfolio in Q4 2024, for an estimated $2,379,896
- FIRST TRUST ADVISORS LP added 122,651 shares (+inf%) to their portfolio in Q3 2024, for an estimated $2,748,608
- ASSENAGON ASSET MANAGEMENT S.A. removed 121,208 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $2,716,271
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SPARTANNASH Government Contracts
We have seen $28,212 of award payments to $SPTN over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.